About the journal
Brain Tumor Pathology is a journal published by Springer Science+Business Media in Japan. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,860 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1433-7398 · 1861-387X
- Country
- Japan
- Access
- Not open access / not declared
- Declared publication charge
- 3,860 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/10014
Index listings
- MEDLINE · 1997-01-01
- Indexing
- MEDLINE
- APC
- 3,860 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 142 days received→accepted — computed from PubMed (n=54)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
849
Last recorded publication year
2026
h-index
54
i10-index
463
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 78%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 9716507
- Society affiliations
- The Japan Society of Brain Tumor Pathology
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Glioma Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Meningioma and schwannoma management
- Meningioma and schwannoma management
- Neurofibromatosis and Schwannoma Cases
- Neurofibromatosis and Schwannoma Cases
- Neuroblastoma Research and Treatments
- Neuroblastoma Research and Treatments
Show all subjects (50)
- Brain Metastases and Treatment
- Brain Metastases and Treatment
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Chromatin Remodeling and Cancer
- Chromatin Remodeling and Cancer
- Vascular Malformations Diagnosis and Treatment
- Vascular Malformations Diagnosis and Treatment
- Pituitary Gland Disorders and Treatments
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Pituitary Gland Disorders and Treatments
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Radiomics and Machine Learning in Medical Imaging
- Radiomics and Machine Learning in Medical Imaging
- Hedgehog Signaling Pathway Studies
- Hedgehog Signaling Pathway Studies
- Bone Tumor Diagnosis and Treatments
- Head and Neck Surgical Oncology
- Head and Neck Surgical Oncology
- Bone Tumor Diagnosis and Treatments
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Cancer-related molecular mechanisms research
- Ocular Oncology and Treatments
- Cancer-related molecular mechanisms research
- Ocular Oncology and Treatments
- Soft tissue tumor case studies
- Soft tissue tumor case studies
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Adrenal and Paraganglionic Tumors
- Cerebrospinal fluid and hydrocephalus
- Adrenal and Paraganglionic Tumors
- Cerebrospinal fluid and hydrocephalus
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ